Westfield Capital Management CO LP Alnylam Pharmaceuticals, Inc. Transaction History

Westfield Capital Management CO LP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 13, 2020	SELL	$104.21 - $156.44 $14.5 Million - $21.7 Million	-138,664 Closed	0 $0
Q1 2020 May 14, 2020	SELL	$93.12 - $133.99 $10.3 Million - $14.8 Million	-110,345 Reduced 44.31%	138,664 $15.1 Million
Q4 2019 Feb 13, 2020	SELL	$74.51 - $124.23 $2.33 Million - $3.89 Million	-31,288 Reduced 11.16%	249,009 $28.7 Million
Q3 2019 Nov 08, 2019	SELL	$70.9 - $87.82 $11 Million - $13.7 Million	-155,736 Reduced 35.72%	280,297 $22.5 Million
Q2 2019 Aug 13, 2019	BUY	$65.86 - $92.79 $7.65 Million - $10.8 Million	116,110 Added 36.29%	436,033 $31.6 Million
Q1 2019 May 14, 2019	BUY	$72.76 - $93.45 $3.6 Million - $4.62 Million	49,480 Added 18.3%	319,923 $29.9 Million
Q4 2018 Feb 08, 2019	BUY	$62.67 - $88.33 $6.24 Million - $8.8 Million	99,588 Added 58.29%	270,443 $19.7 Million
Q3 2018 Nov 14, 2018	SELL	$87.52 - $122.67 $5.01 Million - $7.03 Million	-57,285 Reduced 25.11%	170,855 $15 Million
Q2 2018 Aug 13, 2018	BUY	$88.31 - $107.8 $20.1 Million - $24.6 Million	228,140 New	228,140 $22.5 Million

649

109M

1.28M

1.22M

Ticker ALNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 123,028,000
Market Cap $34.3B
Description
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...

Get notified when there are updates to the investment portfolio of Westfield Capital Management CO LP, based on Form 13F filings with the SEC.

Stay updated on Westfield Capital Management CO LP with notifications on news.